Niki BioSolutions, Inc. (NIKI) — Financial Flexibility Index
Niki BioSolutions, Inc. (NIKI) has a Financial Flexibility Index of -0.11x as of December 2025. Free cash flow of $-535.25K (operating CF $-535.25K minus capex $5.00) represents 0% of total liabilities ($4.90 Million). Explore Niki BioSolutions, Inc. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Niki BioSolutions, Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Niki BioSolutions, Inc. across 9 annual periods. Check Niki BioSolutions, Inc. (NIKI) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for Niki BioSolutions, Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Niki BioSolutions, Inc.. For the full cash flow conversion analysis, see NIKI cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.37x | $-1.84 Million | $-1.84 Million | $4.90 Million | ▼ -37.1% |
| 2024 | -0.27x | $-1.19 Million | $-1.19 Million | $4.35 Million | ▲ +81.4% |
| 2023 | -1.47x | $-7.72 Million | $-7.72 Million | $5.26 Million | ▼ -57.8% |
| 2022 | -0.93x | $-12.13 Million | $-12.32 Million | $13.03 Million | ▲ +71.8% |
| 2021 | -3.30x | $-14.51 Million | $-14.65 Million | $4.40 Million | ▼ -27.1% |
| 2020 | -2.59x | $-15.77 Million | $-15.93 Million | $6.08 Million | ▼ -92.4% |
| 2019 | -1.35x | $-12.28 Million | $-13.38 Million | $9.10 Million | ▼ -318.7% |
| 2018 | -0.32x | $-3.97 Million | $-10.04 Million | $12.33 Million | ▲ +84.3% |
| 2017 | -2.05x | $-2.72 Million | $-5.78 Million | $1.33 Million | — |